Issued Patents All Time
Showing 1–25 of 45 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12070500 | Use of semaphorin-4D antibodies in combination with an immune modulating therapy to inhibit tumor growth and metastasis | Elizabeth E. Evans, Maurice Zauderer | 2024-08-27 |
| 12006364 | Anti-CD100 antibodies and methods for using the same | Terrence Lee Fisher | 2024-06-11 |
| 12006365 | Human anti-semaphorin 4D antibody | Angelica A. Cornelison, Maria G. M. Scrivens, Mark Paris, Maurice Zauderer | 2024-06-11 |
| 11981730 | Anti-CXCL13 antibodies and methods of using the same | Ekaterina Klimatcheva, Mark Paris | 2024-05-14 |
| 11976383 | Integral membrane protein display on poxvirus extracellular enveloped virions | Maria G. M. Scrivens, Loretta Mueller, Shuying Shi, Leslie A. Balch | 2024-05-07 |
| 11859000 | Anti-CCR8 antibodies and uses thereof | Pamela M. Holland, Andrew Lake, Austin DULAK, Maria G. M. Scrivens, Caroline Harvey +4 more | 2024-01-02 |
| 11572408 | Treatment of cancer with a semaphorin-4D antibody in combination with an epigenetic modulating agent | Elizabeth E. Evans, Maurice Zauderer | 2023-02-07 |
| 11534488 | Use of semaphorin-4D binding molecules for modulation of blood brain barrier permeability | Maurice Zauderer | 2022-12-27 |
| 11427634 | Human anti-semaphorin 4D antibody | Angelica A. Cornelison, Maria G. M. Scrivens, Mark Paris, Maurice Zauderer | 2022-08-30 |
| 11274149 | Anti-CD100 antibodies and methods for using the same | Terrence Lee Fisher | 2022-03-15 |
| 11078295 | Use of semaphorin-4D inhibitory molecules with an immune modulating therapy to inhibit tumor growth and metastases | Elizabeth E. Evans, Maurice Zauderer | 2021-08-03 |
| 10870707 | Integral membrane protein display on poxvirus extracellular enveloped virions | Mark Paris, Maria G. M. Scrivens, Renee Kirk, Angelica A. Cornelison | 2020-12-22 |
| 10829550 | Polynucleotides encoding anti-CXCL13 antibodies | Ekaterina Klimatcheva, Mark Paris | 2020-11-10 |
| 10800853 | Use of semaphorin-4D binding molecules for treating neurodegenerative disorders | Maurice Zauderer, William Bowers, Alan Jonason | 2020-10-13 |
| 10662422 | Method for selecting polynucleotides encoding antigen-specific immunoglobulin subunit | Tracy Pandina, Leslie A. Balch, Mark Paris, Maurice Zauderer, Angelica A. Cornelison +1 more | 2020-05-26 |
| 10640765 | Methods for producing polynucleotide libraries in vaccinia virus/eukaryotic cells | Shuying Shi | 2020-05-05 |
| 10577427 | Integral membrane protein display on poxvirus extracellular enveloped virions | Mark Paris, Maria G. M. Scrivens, Renee Kirk, Angelica A. Cornelison | 2020-03-03 |
| 10550199 | Integral membrane protein display on poxvirus extracellular enveloped virions | Mark Paris, Maria G. M. Scrivens, Renee Kirk, Angelica A. Cornelison | 2020-02-04 |
| 10526414 | Use of anti-semaphorin-4D antibodies in combination with an immune modulating therapy to inhibit tumor growth and metastases | Elizabeth E. Evans, Maurice Zauderer | 2020-01-07 |
| 10494440 | Use of semaphorin-4D binding molecules to promote neurogenesis following stroke | Maurice Zauderer | 2019-12-03 |
| 10385136 | Use of semaphorin-4D binding molecules for treating neurodegenerative disorders | Maurice Zauderer, William Bowers, Alan Jonason | 2019-08-20 |
| 10301393 | Methods of treating multiple sclerosis using anti-CD20 antibodies | Terrence Lee Fisher | 2019-05-28 |
| 9963504 | Anti-CXCL13 antibodies and methods of using the same | Ekaterina Klimatcheva, Mark Paris | 2018-05-08 |
| 9890213 | Methods for the treatment of B cell-mediated inflammatory diseases | Maurice Zauderer | 2018-02-13 |
| 9828435 | Use of antibodies or antigen-binding fragments thereof that specifically bind semaphorin-4D to increase tumor infiltrating leukocyte frequency | Elizabeth E. Evans, Maurice Zauderer | 2017-11-28 |